RhDNase showed no clear difference in lung function % change FEV1 compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Erdosteine showed no clear difference in symptoms mucus volume production compared with no treatment (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Erdosteine may leads to higher lung function change in FEV1 (L) at day 15 compared with no treatment (low certainty).
Bromhexine showed no clear difference in adverse events compared with placebo (low certainty).
The review found no eligible studies for this question.
Bromhexine showed no clear difference in symptoms difficulty in expectoration compared with placebo (low certainty).
The review found no eligible studies for this question.
Bromhexine showed no clear difference in lung function FEV1 compared with placebo (low certainty).
The review found no eligible studies for this question.
RhDNase showed no clear difference in hospitalisations for infective exacerbations compared with placebo (low certainty).